INTRODUCTION {#s1}
============

Alzheimer\'s disease (AD) was the main cause for dementia in persons with middle and old age \[[@R1]\], and is a complex and progressive neurodegeneration characterised by large numbers of senile plaques and neurofibrillary tangles in the brain \[[@R2]\]. Clinically, late-onset AD (LOAD) is more common type of AD and the heritability for susceptibility to LOAD could be 80% in previous studies \[[@R3]\]. The etiology and pathogenesis of LOAD are still not clear, AD was a multifactorial disease and the complex pathology was resulted by the interaction of both genetics and environmental factors, however, until recently, the only reliable risk factor, the e4 allele of apolipoprotein E (*APOE*) was verified. It was necessary to find and validate biomarkers for AD prevention, especially for LOAD, which has a strong genetic component \[[@R4]\], and several genes have been identified in the genome-wide association studies \[[@R5], [@R6]\], including the neuronal sortilin-related receptor (*SORL1*) \[[@R7]\] and peroxisome proliferator activated receptor gamma (*PPAR G*) gene \[[@R8]\].

*SORL1* gene locates on chromosome 11q23.2--q24.2 \[[@R9]\]. Recent studies and replication studies have indicated that polymorphisms within *SORL1* gene were associated with susceptibility to AD, which support the association between SNPs within *SORL1* gene and AD risk \[[@R10]- [@R13]\]. However, the other studies concluded controversial results, which indicated a weak or no association between SNPs in *SORL1* gene and AD risk in Caucasian populations \[[@R14]--[@R16]\]. Recently, some studies reported that *PPAR G* can regulate amyloidogenic pathways \[[@R17], [@R18]\], they suggest that *PPAR G* may be a potential candidate gene for AD. However, results on association between *PPAR G* and LOAD were inconsistent yet \[[@R19], [@R20]\]. In addition, LOAD susceptibility could be influenced by both environmental and genetic factors, and their synergistic effects between gene and environment, and previous studies have suggested that alcohol drinking was an important risk factor of LOAD \[[@R21], [@R22]\]. However, till now, less study focused on gene- alcohol drinking interaction on LOAD risk.

In consideration of the previous inconsistent results on association of *PPAR G* and *SORL1* gene with LOAD, less numbers study on gene- alcohol drinking interaction and linkage disequilibrium (LD) among SNPs. In this study, we aimed to investigate the impact of *PPAR G* and *SORL1* gene SNPs, additional gene- gene, gene- environment interaction and haplotype combination on LOAD risk.

MATERIALS AND METHODS {#s2}
=====================

Participants {#s2_1}
------------

In this case-control study, participants were consecutively recruited between January 2009 and November 2014 from the Second Affiliated Hospital of Zhengzhou University. Clinical diagnosis of probable AD is made according to the revised criteria of National Institute of Neurological and Communicative Disorders and Stroke/ Alzheimer\'s Disease and Related Disorders Association (NINCDS/ ADRDA) \[[@R23]\], participants with advanced, severe, progressive, or unstable infectious, metabolic, immunologic, endocrinological, hepatic, hematological, pulmonary, cardiovascular, gastrointestinal, and/or urological diseases are excluded. The detailed participant selection methods have been described in our previous study \[[@R24]\]. Data on demographic information, mini-mental state examination (MMSE), educational year, lifestyle risk factors, smoking and drinking status, prevalence of stroke, prevalence of diabetes and family history of AD for all participants are obtained using a questionnaire administered by trained staffs. Body weight, height and waist circumference (WC) are measured, and body mass index (BMI) are calculated. Blood samples are collected in the morning after at least 8 hours of fasting. All plasma and serum samples are frozen at --80°C until laboratory testing. Plasma glucose is measured using an oxidase enzymatic method. The concentrations of HDL cholesterol and triglycerides are assessed enzymatically using an automatic biochemistry analyzer (Hitachi Inc., Tokyo, Japan) and commercial reagents.

Genomic DNA extraction and genotyping {#s2_2}
-------------------------------------

SNPs within the *SORL1* and *PPAR G* gene were selected according to the following methods: 1) SNPs, which have been reported associations with AD and not been well studied; 2) SNPs, the MAF of which were more than 5%. At last, three SNPs of *SORL1* gene and three SNPs of *PPAR G* gene are selected for genotyping in the study, including: rs709158, rs1805192 and rs10865710 within *PPAR G* gene, rs1784933, rs3824966 and rs689021 within *SORL1* gene. Genomic DNA is extracted from EDTA-treated whole blood, using the DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions. The genotyping methods for *PPAR G* gene have been described in our previous study \[[@R24]\]. Genotyping of three SNPs within *SORL1* gene were performed using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. PCR primer sequences for each polymorphism were shown in Table [1](#T1){ref-type="table"}. The PCR reactions were carried out in a final volume of 25 μl containing: 10 × PCR buffer, 4.5 mM MgCl~2~ (Roche, Germany), 0.4 mM of each dNTP (Fermentas, Germany), 10 pmol of each primer, 30 ng template DNA, 1 U Taq DNA polymerase (Roche, Germany) and sterile distilled water up to 25 μl. PCR conditions were: 94 °C for 15min, then 45 cycles of 94 °C for 20 s, 56 °C for 30 s, and 72 °C for 1min, with a final extension at 72 °C for 30min and then reactions held at 4 °C.

###### Description and Probe sequence for 6 SNPs used for Taqman fluorescence probe analysis

  ------------------------------------------------------------------------------------------------------------------------------------
  SNP ID       Chromosome     Functional Consequence                 Major/ minor alleles   Nucleotide sequences/ Probe sequence
  ------------ -------------- -------------------------------------- ---------------------- ------------------------------------------
  *SORL1*                                                                                   

  rs689021     11:121500411   Intron variant                         T/C                    Forward: ACGTTGGATGACCTTACAGATGATGCAGCC\
                                                                                            Reverse: ACGTTGGATGGGCCATAGTTTCCTAGCATC

  rs3824966    11:121577474   Intron variant                         G/C                    Forward: ACGTTGGATGCCAAGCTAATTCTCAGAGCC\
                                                                                            Reverse: ACGTTGGATGTTGACAGCACTCATCCGTTC

  rs1784933    11:121618707   Intron variant                         G/A                    Forward: ACGTTGGATGTTTGAAGCAGTTCCAGGGTC\
                                                                                            Reverse: ACGTTGGATGGAATGGAAGAGGACATCAGC

  *PPARG*                                                                                   

  rs709158     3:12421677     Intron variant                         A/G                    5'-AGATACGGGGGAGGAAATTCACTGG\[A/G\]\
                                                                                            TTTTACAATATATTTTTCAAGGCAA-3'

  rs10865710   3:12311699     Intron variant, upstream variant 2KB   C/G                    5'-TTGGCATTAGATGCTGTTTTGTCTT\[C/G\]\
                                                                                            ATGGAAAATACAGCTATTCTAGGAT-3'

  rs1805192    3:12379739     Missense                               C/G                    5'-ACCTCAGACAGATTGTCACGGAACA\[C/T\]\
                                                                                            GTGCAGCTACTGCAGGTGATCAAGA-3'
  ------------------------------------------------------------------------------------------------------------------------------------

Statistical analysis {#s2_3}
--------------------

The means and standard deviations (SD) were calculated for normally distributed continuous variables, and percentages were calculated for categorical variables. The categorical data were analyzed using χ^2^ test. Further, continuous variables were analyzed using Student\'s t test. Hardy-Weinberg equilibrium (HWE), haplotype analysis and pairwise LD analysis were investigated by using SNPStats (available online at <http://bioinfo.iconcologia.net/SNPstats>). Logistic regression was performed to investigate association between SNPs and LOAD. Generalized multifactor dimensionality reduction (GMDR) was used to investigate the interaction among gene- gene and gene- environment interaction, cross-validation consistency, the testing balanced accuracy, and the sign test, to assess each selected interaction were calculated. The cross-validation consistency score is a measure of the degree of consistency with which the selected interaction is identified as the best model among all possibilities considered. Testing-balanced accuracy is a measure of the degree to which the interaction accurately predicts case--control status, and yields a score between 0.50 (indicating that the model predicts no better than chance) and 1.00 (indicating perfect prediction). Finally, the sign test, or permutation test (providing empirical P-values), for prediction accuracy can be used to measure the significance of an identified model.

RESULTS {#s3}
=======

A total of 880 participants (514 males, 366 females) were selected, including 430 LOAD patients and 450 control subjects. The mean age of all participants was 81.7 ± 15.9 years old. Table [2](#T2){ref-type="table"} shows the general characteristics, clinical and blood biochemical index for all participants. The cases have the higher alcohol- drinking rate than controls. The means of FPG and TG were significantly higher in cases and controls, but the mean of HDL was lower in cases and controls.

###### General characteristics of 880 study participants in case and control group

  -----------------------------------------------------------------------
  Variables                    Case group\   Normal group\   *p*-values
                               (*n*= 430)    (*n*= 450)      
  ---------------------------- ------------- --------------- ------------
  Age (year)                   81.4±16.1     82.3±15.7       0.401

  Males, N (%)                 246 (57.2)    268(59.6)       0.480

  Smoke, N (%)                 151 (35.1)    145(32.2)       0.364

  Alcohol consumption, N (%)   188 (43.7)    160 (35.6)      0.013

  WC (cm)                      89.2±19.8     87.7±19.4       0.257

  BMI (kg/m^2^)                25.1±8.9      24.8±9.1        0.621

  FPG (mmol/L)                 5.8±1.6       5.5±1.9         0.012

  TG (mmol/L)                  1.4±0.8       1.3± 0.7        0.048

  TC (mmol/L)                  4.6±0.8       4.5±0.9         0.082

  HDL (mmol/L)                 1.21±0.65     1.34±0.63       0.002

  Stroke                       16 (3.72)     20 (4.44)       0.255

  MMSE (scores)                15.16±5.51    29.12±4.97      \<0.001

  Diabetes                     36 (8.37)     43(9.56)        0.539

  Educational year             7.5±3.12      7.8±3.31        0.167
  -----------------------------------------------------------------------

Note: Means± standard deviation for age, WC, BMI, FPG, TC, TG, HDL-C and ANP; TC, total cholesterol; HDL, high density lipoprotein; FPG, fast plasma glucose; TG, triglyceride; WC, waist circumference; BMI, body mass index; MMSE, mini-mental state examination;

In Table [3](#T3){ref-type="table"}, the frequencies for the rs1784933- A allele within *SORL1* gene and rs1805192- G allele within *PPAR G* were significantly higher in LOAD cases than that in controls. The carriers with the rs1784933- A allele have higher LOAD risk than those with GG genotype (GA+ AA versus GG), adjusted OR (95%CI) = 1.63 (1.27-1.98), and the carriers with rs1805192- G allele also have higher LOAD risk than those with CC genotype (CG+ GG versus CC), adjusted OR (95%CI) = 1.70 (1.25-2.27). However, we the others SNP within *SORL1* and *PPAR G* gene were not associated with LOAD susceptibility after covariates adjustment.

###### Genotype and allele frequencies of 6 SNPs between case and control group

  Gene/ SNP    Genotypes and Alleles   Frequencies *N* (%)   OR(95%CI)\*   *P*- values        HWE test for controls   
  ------------ ----------------------- --------------------- ------------- ------------------ ----------------------- -------
  *SORL1*                                                                                                             
  rs689021     Co- dominant                                                                                           
               TT                      271 (60.2)            235(54.6)     1.00                                       0.360
               TC                      152 (33.8)            153(35.6)     1.13 (0.82-1.85)   0.621                   
               CC                      27 (6.0)              42(9.8)       1.40 (0.89-1.98)   0.506                   
               Dominant                                                                                               
               TT                      271 (60.2)            235(54.6)     1.00                                       
               TC +CC                  179(39.8)             195 (45.4)    1.19 (0.83-1.89)   0.605                   
               Allele, C (%)           206(22.9)             237(27.6)                                                
  rs3824966    Co- dominant                                                                                           
               GG                      276(61.3)             243(56.5)     1.00                                       0.691
               GC                      151(33.6)             156(36.3)     1.27(0.95-1.71)    0.236                   
               CC                      23(5.1)               31(7.2)       1.45(0.81-2.22)    0.379                   
               Dominant                                                                                               
               GG                      276(61.3)             243(56.5)     1.00                                       
               GC+CC                   174(38.7)             187(43.5)     1.42(0.92-1.87)    0.252                   
               Allele, C (%)           197(21.9)             218(25.3)                                                
  rs1784933    Co- dominant                                                                                           0.999
               GG                      288(64.0)             198(46.1)     1.00                                       
               GA                      144(32.0)             182(42.3)     1.55(1.24-1.91)    \<0.001                 
               AA                      18(4.0)               50(11.6)      2.08 (1.41-2.92)   \<0.001                 
               Dominant                                                                                               
               GG                      288(64.0)             198(46.1)     1.00                                       
               GA+AA                   162(36.0)             232(53.9)     1.63(1.27-1.98)    \<0.001                 
               Allele, A (%)           180(20.0)             282(32.8)                                                
  *PPAR G*                                                                                                            
  rs1805192    Co- dominant                                                                                           0.073
               CC                      283(62.9)             212(49.3)     1.00                                       
               CG                      139(30.9)             164(38.1)     1.57 (1.21-1.79)   \<0.001                 
               GG                      28(6.2)               54(12.6)      2.15 (1.42-2.98)   \<0.001                 
               Dominant                                                                                               
               CC                      283(62.9)             212(49.3)     1.00                                       
               CG+GG                   167(37.1)             218(50.7)     1.70 (1.25-2.27)   \<0.001                 
               Allele, G (%)           195(21.7)             272(31.7)                                                
  rs10865710   Co- dominant                                                                                           0.226
               CC                      255(56.7)             234(54.4)     1.00                                       
               CG                      161(35.8)             160(37.2)     1.07 (0.86-1.48)   0.628                   
               GG                      34(7.6)               36(8.4)       1.02 (0.70-1.69)   0.746                   
               Dominant                                                                                               
               CC                      255(56.7)             234(54.4)     1.00                                       
               CG+GG                   195(43.4)             196(45.6)     1.06 (0.87-1.51)   0.656                   
               Allele, G (%)           229(25.4)             232(27.0)                                                
  rs709158     Co- dominant                                                                                           
               AA                      263(58.4)             240(55.8)     1.00                                       0.836
               AG                      161(35.8)             157(36.5)     1.02 (0.81-1.41)   0.434                   
               GG                      26(5.8)               33(7.7)       1.11 (0.78-1.62)   0.592                   
               Dominant                                                                                               
               AA                      263(58.4)             240(55.8)     1.00                                       
               AA+GG                   187(41.6)             190(44.2)     1.05 (0.80-1.45)   0.483                   
               Allele, G (%)           213(23.7)             223(25.9)                                                

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

GMDR analysis was used to investigate the impact of the interaction among 6 SNPs within *SORL1* and *PPAR G* gene on LOAD risk. Table [4](#T4){ref-type="table"} shows a significant two-locus model (p = 0.0010) involving rs1784933 and rs1805192, and in this model, the cross- validation consistency was 9/ 10, and the testing accuracy was 62.70%. We also found a significant two-locus model (p = 0.0100) involving rs1784933 and alcohol drinking, and in this model, the cross-validation consistency was 10/ 10, and the testing accuracy was 60.72%, after covariates adjustment for alcohol consumption status, FPG, TG and HDL (Table [5](#T5){ref-type="table"}).

###### Best gene--gene interaction models, as identified by GMDR

  Locus no.                       Best combination                                                              Cross-validation consistency   Testing accuracy   *p-values*\*
  ------------------------------- ----------------------------------------------------------------------------- ------------------------------ ------------------ --------------
  Gene- gene interaction                                                                                                                                          
  2                               rs1784933 rs1805192                                                           9/10                           0.6270             0.0010
  3                               rs1784933 rs1805192 rs10865710                                                8/10                           0.5399             0.0547
  4                               rs1784933 rs1805192 rs10865710 rs3824966                                      7/10                           0.5399             0.1719
  5                               rs1784933 rs1805192 rs10865710 rs3824966 rs689021                             7/10                           0.4958             0.3770
  6                               rs1784933 rs1805192 rs10865710 rs3824966 rs689021 rs709158                    6/10                           0.4958             0.4258
  Gene- environment interaction                                                                                                                                   
  2                               rs1784933 alcohol drinking                                                    10/10                          0.6072             0.0100
  3                               rs1784933 rs1805192 alcohol drinking                                          8/10                           0.5399             0.1719
  4                               rs1784933 rs1805192 rs10865710 alcohol drinking                               7/10                           0.5399             0.1719
  5                               rs1784933 rs1805192 rs10865710 rs3824966 alcohol drinking                     6/10                           0.4958             0.4258
  6                               rs1784933 rs1805192 rs10865710 rs3824966 rs689021 alcohol drinking            5/10                           0.4958             0.3770
  7                               rs1784933 rs1805192 rs10865710 rs3824966 rs689021 rs709158 alcohol drinking   6/10                           0.4958             0.9893

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

###### The D' values among SNPs within *PPAR G* and *SORL1* gene for the linkage disequilibrium test

  SNPs            D' values    
  --------------- ------------ ----------
  *PPAR G* gene   rs10865710   rs709158
  rs1805192       0.362        0.623
  rs10865710      \-           0.482
  *SORL1* gene    rs3824966    rs689021
  rs1784933       0.548        0.823
  rs3824966       \-           0.617

Pairwise LD analysis between SNPs was performed and D' values were shown in Table [5](#T5){ref-type="table"}, we found that just D′ value between rs1784933 and rs689021 within *SORL1* gene was 0.823, which shown a strong chain reaction. So we also conducted haplotype analysis between the two SNPs. We found that the most common haplotype in *SORL1* gene was rs1784933- G and rs689021- T haplotype, the frequency of which was 0.4701 and 0.5467 in case group and control group. Haplotype containing the rs1784933- A and rs689021- C alleles were associated with a statistically increased LOAD risk (OR = 1.86, 95%CI = 1.37-- 2.52, *P* \< 0.001) (Table [6](#T6){ref-type="table"}).

###### Haplotype analysis on association between *SORL1* gene and LOAD risk

  Haplotypes   rs1784933   rs689021   Frequencies   OR (95%CI)   *p-values*\*          
  ------------ ----------- ---------- ------------- ------------ --------------------- ---------
  H1           G           T          0.4701        0.5467       1.00                  \--
  H2           A           T          0.2167        0.2131       1.17 (0.84-- 1.68)    0.590
  H3           G           C          0.2035        0.1921       1.28 (0.92 - 1.75)    0.612
  H4           A           C          0.1097        0.0481       1.86 (1.37 -- 2.52)   \<0.001

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

DISCUSSION {#s4}
==========

In this study, we found that both the rs1784933- A allele and the rs1805192- G allele were associated with increased LOAD risk. However, we the others SNP within *SORL1* and *PPAR G* gene were not associated with LOAD susceptibility after covariates adjustment. Some studies have focused on the association between *PPAR G* and AD risk, however the results on this association were inconsistent. Some studies concluded different results in Finnish \[[@R19]\], Japanese \[[@R25]\] and Asians and Caucasians population \[[@R20]\], these studies indicated that SNP and haplotype analyses for *PPAR G* gene were not significant associated with AD risk, so they conclude that *PPAR G* did not related with AD in the Finnish population. However, some studies also confirmed a significant association of SNPs within *PPAR G* with AD \[[@R17], [@R18]\].

Although this was not the first association study focused on the SNP of *SORL1* polymorphism and the risk of LOAD risk, however, they also did not concluded consistent results. In 2007, Rogaeva et al \[[@R26]\] firstly reported an association between SNP in *SORL1* gene and AD incidence. From then on, several population- based studies were conducted for other populations. Minster et al \[[@R15]\] suggested no association with LOAD risk in their cohort. The data by Liu et al \[[@R27]\] also suggested the similar results on relationship between genetic variants in *SORL1* and the risk of AD. Some studies also found positive results on this association, which were similar with results obtained in current study. Kölsch et al \[[@R28]\] found that *SORL1* gene variants were associated with increased AD risk. Bettens et al \[[@R10]\] also indicated a significant association between common SNP within *SORL1* gene and LOAD, providing further evidence of genetic variations in *SORL1* affecting susceptibility of LOAD. In a Japanese population, Kimura et al \[[@R29]\] found that *SORL1* was genetically associated with Alzheimer disease, and the similar results were also obtained from the others studies \[[@R30]- [@R32]\].

In this study, we found that LOAD risk was determined by both *SORL1* and PPAR G gene, and synergistic reaction of both gene and environmental factors, so we also conducted analysis on impact of gene- gene and gene- environment interaction on LOAD risk. We found a significant gene- gene interaction involving rs1784933 and rs1805192, and a significant gene- environment interaction involving rs1784933 and alcohol drinking. Previously, several environmental risk factors have been reported, including alcohol drinking \[[@R21], [@R22]\], which was associated with LOAD in this study. Previously just one study focused on the impact of interaction between *SORL1* rs2070045 polymorphism and *ApoE* genotype with the late-onset Alzheimer\'s disease, but they showed no interaction effect between *ApoE 4* and any of the rs2070045 genotypes. In this study we also conducted the haplotype analysis for the rs1784933 and rs689021 within *SORL1* gene, the D' value of which was more than 0.8 (0.823), we found a haplotype containing the rs1784933- A and rs689021- C alleles were associated with a statistically increased LOAD risk.

The current study has some limitations, which should be considered. Firstly, limited number of SNPs in *SORL1* and *PPAR G* gene was included in this study, and in the future, more SNPs should be included in analysis. Secondly, more environmental factors should be included in the gene- environment analysis, not only for alcohol drinking. Thirdly, the results of interaction analysis should be checked in different population, not only in Chinese Han.

In conclusion, we found that rs1784933 and rs1805192 minor alleles were associated with increased LOAD risk. We also found a significant gene- gene interaction between rs1784933 and rs1805192, gene- environment interaction between rs1784933 and alcohol drinking, and haplotype containing the rs1784933- A and rs689021- C alleles were all associated with increased LOAD risk.
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